Khaitan Baker amp Mckenzie Latham and Amarchand lead on US based Hospiras acquisition of Orchids API manufacturing RampD units for 200 million

Khaitan Baker amp Mckenzie Latham and Amarchand lead on US based Hospiras acquisition of Orchids API manufacturing RampD units for 200 million
Published on
2 min read

Hospira Inc. has entered into an agreement to acquire the API manufacturing facility along with an associated research and development (R&D) facility of Orchid Chemicals & Pharmaceuticals. The deal is valued at $200 million (Rs.1112 crore).

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com